Penicillin tolerance in Arcanobacterium haemolyticum

M Nyman1, G Banck, M Thore

  • 1Department of Infectious Diseases, Malmö General Hospital, University of Lund, Sweden.

Insights

Arcanobacterium haemolyticum causes tonsillitis but is often tolerant to penicillin. This penicillin tolerance suggests that phenoxymethylpenicillin may be ineffective for eradicating this bacterium from the pharynx.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Arcanobacterium haemolyticum is a pathogen causing tonsillitis with exanthema.
  • Phenoxymethylpenicillin is often prescribed for bacterial pharyngitis.
  • Previous studies indicate phenoxymethylpenicillin fails to eradicate A. haemolyticum from the pharynx despite low minimum inhibitory concentrations.

Purpose of the Study:

  • To investigate the phenomenon of penicillin tolerance in recent clinical isolates of Arcanobacterium haemolyticum.
  • To determine the prevalence and degree of penicillin tolerance in A. haemolyticum.
  • To assess the clinical implications of penicillin tolerance for A. haemolyticum infections.

Main Methods:

  • Disk diffusion screening tests were employed to assess penicillin tolerance.
  • Pour plate assays were utilized to quantify penicillin tolerance.
  • Macrobroth dilution methods determined minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs).
  • Antibiotic kill kinetics were analyzed for select isolates.

Main Results:

  • Penicillin tolerance was detected in 38 out of 40 clinical isolates using the disk diffusion assay.
  • The pour plate assay revealed all 40 isolates were tolerant, with 34 exhibiting high tolerance.
  • Macrobroth dilution assays confirmed the presence of the tolerant phenotype.

Conclusions:

  • Arcanobacterium haemolyticum frequently exhibits a penicillin-tolerant phenotype.
  • This tolerance suggests that phenoxymethylpenicillin treatment may be ineffective for eradicating A. haemolyticum from the pharynx.
  • Further research into alternative treatment strategies for A. haemolyticum infections is warranted.

Related Concept Videos

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...